title: In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
authors.affiliation: Department of Cell Culture and Molecular Biology, Venus Medicine Research Centre, Baddi, India.
authors.forename: Manu
authors.initials: M
authors.lastname: Chaudhary
authors.forename: Shailesh
authors.initials: S
authors.lastname: Kumar
authors.forename: Anurag
authors.initials: A
authors.lastname: Payasi
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial; D004492:Edetic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007709:Klebsiella / Q000187:drug effects* / Q000302:isolation & purification; D007710:Klebsiella Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D013407:Sulbactam / Q000008:administration & dosage / Q000494:pharmacology*; D047090:beta-Lactams / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D047090:beta-Lactams; D004492:Edetic Acid; D013407:Sulbactam